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ABSTRACT
Objective: To compare sterility and microbial (bacteria and fungi) load 
in the outer part of hyperbaric bupivacaine (Neocaína®) in ampoule 
and bupivacaine in vial, in conventional and sterile pack formulations. 
Methods: The sterile packs were divided into two groups: G1 (n=16) 
with ampoules and G2 (n=16) with vials. Conventional formulations 
were divided into two groups, being G3 (n=16) with ampoules and 
G4 (n=16) with vials. The ampoules and vials were opened and had 
their content drawn. The empty bottles were then placed in sterile 
plastic bags and sent for analysis of microbial load (bacteria and 
fungi) and sterility testing. Data were analyzed using the χ2 test with 
Yates correction, and 95% confidence interval. Results: G1 and G2 
showed no bacterial growth when compared to conventional groups 
(p<0.001). The most common agent in conventional microbiological 
samples was Staphylococcus aureus. There was no fungal growth 
in both groups. Conclusion: The use of (sterile pack) reduces the 
microbial load of bottles, and would decrease the chance of exposure 
to potential contamination of the anesthetic solution.
Keywords: Infection control; Anesthesia; Contamination; Anesthesia, 
conduction
RESUMO
Objetivo: Comparar a esterilidade e a carga microbiana (bactérias e 
fungos) da parte externa dos frascos de envasamento de bupivacaína 
hiperbárica (Neocaína®) em ampola e bupivacaína em frasco-ampola 
das apresentações convencional e estéril (sterile pack). Métodos: 
As apresentações estéreis (sterile pack) foram distribuídas em dois 
grupos, sendo que o G1 (n=16) continha as ampolas e o G2 (n=16), os 
frascos-ampola. As apresentações convencionais foram distribuídas 
em dois grupos, a saber G3 (n=16) com as ampolas e G4 (n=16) com 
os frascos-ampola. As ampolas e os frascos-ampolas eram abertos 
e tinham seu conteúdo aspirado. Os frascos vazios eram, então, 
acondicionados em sacos plásticos estéreis e enviados para análise 
quanto à carga microbiana (bactérias e fungos), bem como para o 
teste de esterilidade. Os dados foram analisados por meio do teste χ2 
com correção Yates com intervalo de confiança de 95%. Resultados: 
Os grupos G1 e G2 não apresentaram crescimento bacteriano quando 
comparado aos grupos convencionais (p<0,001). O microbiano mais 
comum nas amostras convencionais foi o Staphylococcus aureus. Não 
houve crescimento de fungos em nenhum dos grupos. Conclusão: O 
uso de embalagens estéreis (sterile pack) diminui a carga microbiana 
dos frascos de envasamentos, o que diminuiria a chance de exposição 
a uma potencial contaminação da solução anestésica.
Descritores: Controle de infecções; Anestesia; Contaminação; Anestesia 
por condução
INTRODUCTION
In the past years, modern medicine has used spinal 
(peridural, subarachnoid or dual block) anesthesia 
in many situations. It is used primarily in obstetrics, 
gynecology and lower limb surgeries, as well as in 
treatment of acute and chronic postoperative pain.(1) 
However this technique might present complications, 
including some severe events, such as traumatic 
nerve lesions, peridural hematomas, infections like 
peridural and paravertebral abscess, and acute bacterial 
meningitis.(2-5)
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infections. In the anesthetic practice, invasive procedures 
- such as tracheal intubation, venous access or blocking 
nerve bundles - are routinely performed and they break 
through physiologic barriers, allowing contamination 
of the patient by microorganisms and development 
of infection. Non-compliance with the recommended 
practices may facilitate transmission of microorganisms 
from the anesthesiologist to the patient, from the 
patient to the anesthesiologist, and among patients.(12) 
Hygiene practices by professionals, proper cleaning of 
equipment and appropriate performance of invasive 
procedures are relevant aspects to reduce the risk of 
transmitting infection.(6)
The local anesthetics and opioids that are usually 
administered by peridural or subarachnoid routes are 
available in recipients, whose external parts are exposed 
to environmental pathogens, and are a potential source 
of contamination. Opening and handling the ampoules 
are generally not performed in a standardized manner. 
Possible contamination can occur during the several 
stages of the process, involving handling of the ampoule 
up to administration of its content. 
OBJECTIVE
To compare sterility and microbial (bacteria and fungi) 
load in the outer part of hyperbaric bupivacaine 
(Neocaína®) in ampoule and bupivacaine in vial, in 
conventional and sterile pack formulations.
METHODS
The study was carried out in the operating room of 
Hospital São Paulo, under coordination of the anesthesia 
service, Department of Anesthesiology, Pain and 
Intensive Medicine, Universidade Federal de São Paulo, 
Escola Paulista de Medicina, under protocol number 
0860/11, approved by the Research Ethics Committee.
The sterile packs of Neocaína® (Cristália Produtos 
Químicos e Farmacêuticos, São Paulo, Brazil) were 
distributed into two groups: G1 with 4mL ampoules of 
0.5% bupivacaine hydrochloride + 8% glucose) and 
G2 with 20mL vials of 0.5% bupivacaine hydrochloride 
without vasoconstrictors). 
The conventional formulations of Neocaína® (Cristália 
Produtos Químicos e Farmacêuticos, São Paulo, Brazil) 
were distributed into two groups: G3 with ampoules 
and G4 with vials.
The analysis was carried with 16 samples of each 
group, totaling up 64 samples. The samples were 
collected between 7:00 a.m. and 11:00 a.m., during 5 
Endogenous or exogenous sources of microorganisms 
may enter the subarachnoid or peridural spaces by 
direct inoculation, hematogenous dissemination from 
other sites or migration through the catheter, via skin or 
tissue subcutaneous. Several case reports suggested the 
microorganisms of the patient’s or anesthesiologist’s 
microbiota can be directly inoculated when the needle 
or the catheter is inserted in these spaces, or when the 
anesthetic vial solutions are administered to patients, 
and the outer part of vials is not sterile.(6) Many 
investigators collected cultures of needles, syringes and 
tubes used to administer regional anesthesia, aiming 
to check when these items become contaminated for 
use and, consequently, may be a source of infection. 
Some studies demonstrated that the incidence of device 
contamination ranged from zero to 33%, but no 
investigator identified infected patients. In addition, 
they could not correlate the source of contamination 
with infection.(6,7)
There are reports in the literature of cases of 
meningitis after regional anesthesia.(2) There are 
multiple mechanisms proposed as source of meningeal 
infection. First, the microorganism may be introduced 
during the insertion of a contaminated needle or 
catheter, which could explain most cases related to 
spinal anesthesia. The microorganisms involved are 
Staphylococcus aureus and Streptococcus spp., described 
in more than 50% of cases. Sometimes the origin of these 
microorganisms is the physician’s nasopharynx.(8) This 
situation may occur when asepsis measures during the 
procedure are not adequate, such as the team involved in 
block aesthesia does not wear the mask correctly. Second, 
needles and catheters can be contaminated by bacteria 
that live on the skin and may later migrate along the skin 
surface to the subarachnoid space.(9) This would explain 
most infections secondary to chronic spinal analgesia, 
and the most common agent is Staphylococcus aureus. 
Third, there may be a hematogenous dissemination 
of a distant source of infection, and contamination of 
the subarachnoid space occurs with blood flow during 
puncture.(10) Finally, the infusion of contaminated 
substances was the cause in a few cases, and some 
of them were fatal.(10) The etiologic spectrum of 
meningitis associated to regional anesthesia is broad, 
including viridans group Streptococcus, other species of 
Streptococcus, Staphylococcus aureus, Pseudomonas spp., 
Enterococcus faecalis, Corynebacterium, Acinetobacter and 
even Aspergillus.(11)
Although rare, the infectious complications of regional 
anesthesia can be devastating. The anesthesiologists 
play an important role in prevention of nosocomial 
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days. These drugs were delivered from the pharmacy 
of the Hospital São Paulo, through the natural flow of 
medications and were not necessarily from the same 
batch.
The samples were carefully identified considering 
date and time, kept under refrigeration and sent to the 
laboratory. 
The sample flow is displayed in figure 1.
syringe, or removed the vial cap to withdraw the whole 
content using a 20mL syringe. After this procedure, the 
anesthesiologist placed the sterile pack ampoules and 
vials inside sterile bags.
In the conventional groups G3 and G4, the recipients 
were not cleaned before use, according to usual clinical 
practice. In the group G3, the assistant opened the 
ampoule and held it for the anesthesiologist to withdraw 
the content using a 5mL syringe. In the group G4, the 
assistant removed the cap of the vial and held it for the 
anesthesiologist to withdraw the content using a 20mL 
syringe. Then the assistant placed the conventional 
ampoules and vials in sterile bags. 
After closure, the sterile bags were stored in a 
refrigerator at +4°C-+8°C, until all samples of the day 
were collected. Later they were sent to the laboratory 
Controlbio Assessoria Técnica Microbiológica S/S Ltda., 
which complies with the international standards ISO 
11137-1:2006 and ISO 11137-2:2006. 
Although the initial sample collection was not blinded 
due to the handling routine, the laboratory staff that 
analyzed the samples was not aware of the groups. 
Qualitative and quantitative analyses of ampoules 
and vials were performed for microbial load on their 
outer surface. Under rotation, the vials were placed on 
blood agar plates, incubated at 30°C -35°C, for 72 hours. 
Afterwards the plates were read in a colony counter.
The microorganisms were identified by biochemical 
tests and culturing for fungus, and BBL Crystal™ for 
bacteria.
For the sterility test, ampoules and vials were immersed 
in 50mL of a liquid medium (Soybean-Casein Digest 
Medium or similar). These samples were incubated at 
30°C -35°C, for 14 days. After this period, the culture 
medium was assessed regarding turbidity. An aliquot 
was withdrawn from the turbid vials for subculture and 
identification of microorganisms, by means of Gram 
staining and BBL Crystal™ kit.
Date were analyzed using the Yates corrected χ2 test 
and 95% confidence interval. 
RESULTS
The results were analyzed according to the study groups.
Sterile pack versus conventional ampoule 
Bacterial growth was observed in 13 out of 16 (81.25%) 
conventional ampoule samples; in that, seven were 
Staphylococcus aureus seven Bacillus spp and one had 
Micrococcus spp. Some samples had different species. 
No fungal growth was reported in the samples. 
Figure 1. Sample flow
The anesthesiologist wore cap and mask for collection 
and did hand asepsis with chlorhexidine before handling 
the medication, according to the routine of the 
operating room, and put on sterile gloves. One assistant, 
appointed by the anesthesiologist, removed and handled 
the conventional ampoule and vial. The principal 
investigator assured standardization of collections in 
the different groups.
In groups G1 and G2, the assistant opened the 
sterile pack of the ampoule and vial, and placed 
them on a sterile tray. The anesthesiologist broke the 
ampoule neck to withdraw all content using a 5mL 
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The sterile pack ampoules had no bacterial or 
fungal growth in the assays. This difference in the 
χ2 test was 18.656, with one degree of freedom and 
p<0.0001.
Sterile pack versus conventional vial 
Fifteen out of 16 (93.75%) conventional vial samples had 
bacterial growth. Twelve samples with Staphylococcus 
aureus six with Bacillus spp and three with Micrococcus 
spp, and some samples had different species. No fungal 
growth was described in the samples. 
The sterile pack vials had no bacterial or fungal 
growth in the assays. This difference in the χ2 test was 
24.596, with one degree of freedom and p<0.0001. 
Table 1 shows the microbial culture results in the 
conventional groups.
As to microbial load, the results showed no pathogen 
growth in sterile pack ampoules and vials when comparing 
to conventional recipients. This finding would contribute 
to lower risk of microbial contamination in anesthetic 
solutions. However, this article has a limiting factor: it 
was not possible to confirm the relevance of solution 
contamination dependent on the type of package, because 
the methods used in the present study did not include 
analysis of the ampoule and vial contents. 
A previous study had already demonstrated the 
likelihood of contamination of the injected solution due 
to a contaminated ampoule is approximately 1.66%. This 
would require a 15-fold larger sample in our study.(15) 
Further studies must be conducted to prove this causal 
relation.
Although rare,(16) complications of microbial infections 
during anesthesia must be considered, and meningitis 
is one of the most important. The literature describes 
Staphylococcus aureus as the most frequent etiology of 
complications during neuroaxis regional block.(9,17) This 
datum corroborates the findings of the current study, 
since this agent was found in 54% of conventional 
ampoule and in 80% of conventional vial samples. 
There was no growth of Streptococcus spp probably due 
to the team wearing facial masks when handling vials 
during the anesthetic blocks, as per the protocol.
Although infection during neuroaxis anesthesia 
may occur during insertion of the needle, or because of 
failures in sterile techniques, there are reports on injection 
of contaminated solution.(18) This fact is not broadly 
disseminated, but such injection may lead to devastating 
infectious complications in regional anesthesia. When 
handling all materials, the anesthesiologists should give 
priority to practices that minimize contamination. 
CONCLUSION
The use of sterile packages can reduce the exposure to 
potential contamination of infused anesthetic solutions. 
Besides that, anesthesiologists will demand less assistance 
and, consequently, will feel more confident during the 
preparation of material needed for regional anesthesia.
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